The Open Targets Blog
OCTOBER 24, 2023
Amir Feizi is the Director of Bioinformatics at OMass Therapeutics, a spinout from Professor Dame Carol Robinson’s Laboratory at the University of Oxford. Their work was recently published in Bioinformatics. We chat with him about otargen, and the importance of sharing open-source resources within the bioinformatics community.
The Pharma Data
NOVEMBER 15, 2020
” Arthur Oubrie, Chief Scientific Officer of Lead Pharma, added: “This is the second project we partner with one of the largest pharmaceutical companies under our Discover, Design and Deliver platform. . Lead Pharma may receive payments of up to €260 million plus royalties on sales. OSS, Netherlands , Nov.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Pharma Data
NOVEMBER 25, 2020
Egle has leveraged its unique bioinformatic and translational capabilities to successfully identify targets that will now be pursued under the terms of the alliance.
Elrig
APRIL 29, 2024
Harini Srinivasan is a Principal Scientific Associate at Serna Bio with over 10 years of research experience in academic institutions, health care organizations and pharmaceutical companies. Bioinformatics is all about bringing together different areas of knowledge. Do you think the current talent pool supply meets the demand?
Practical Cheminformatics
JANUARY 8, 2024
While large pharmaceutical companies have data on thousands or even millions of compounds, this data is rarely shared due to intellectual property concerns. The authors suggest that federated learning provides one potential solution to the data-sharing conundrum. For classification models, the participants reported a median 2.5-7.5%
The Pharma Data
MARCH 2, 2021
As a world-leading, research-driven pharmaceutical company, more than 51,000 employees create value through innovation daily for our three business areas: Human Pharma, Animal Health, and Biopharmaceutical Contract Manufacturing.
Broad Institute
AUGUST 20, 2024
After graduating with a bachelor’s degree in bioinformatics, Qin then went on to pursue her PhD at UCSD, where she used computational modeling to study how proteins interact with each other and assemble into a human cell. Hopefully this can inspire new therapeutic developments from pharmaceutical companies.
Expert insights. Personalized for you.
62 
Let's personalize your content